Metabolic abnormalities and use of HIV-1 protease inhibitors

Lancet. 1998 Sep 5;352(9130):821-2. doi: 10.1016/S0140-6736(05)60719-2.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • HIV Protease / metabolism*
  • HIV Protease Inhibitors / pharmacology*
  • Humans
  • Insulin / metabolism*
  • Insulin Resistance
  • Liver / metabolism

Substances

  • HIV Protease Inhibitors
  • Insulin
  • HIV Protease